Application 761378
- Type
- BLA
- Sponsor
- FORMYCON AG
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761378 | Ahzantive | aflibercept-mrbb | 351(k) Biosimilar | Rx | 2026-09-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AHZANTIVE | AFLIBERCEPT-MRBB | INJECTABLE;INJECTION | 2MG(0.05ML OF 40MG/ML) | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 82033 | SUPPL | 2025-04-28 |
| 81627 | ORIG | 2025-03-18 |
| 78969 | ORIG | 2024-07-02 |
| 78942 | ORIG | 2024-07-01 |